Products

LungVision
BodyVision Medical
Oncology AI
BodyVision Medical's LungVision system is an AI-powered intraoperative imaging and navigation platform that transforms 2D C-arm X-rays into real-time 3D CT-like scans for precise lung cancer diagnosis and intervention.

See all 1 product →

About BodyVision Medical

BodyVision Medical is a commercial-stage healthcare AI company dedicated to revolutionizing lung cancer diagnostics and treatment through advanced intraoperative imaging. Their flagship product, LungVision®, is an AI-powered system designed to address the significant challenges faced by interventional pulmonologists and thoracic surgeons during bronchoscopic procedures. The system uniquely transforms standard 2D X-ray images from any conventional C-arm into real-time 3D imaging, providing clinicians with unprecedented visualization capabilities within the lung.

A primary focus of BodyVision Medical’s technology is to overcome the issue of CT-to-body divergence, which often hinders the accurate localization and biopsy of small, peripheral lung lesions. By offering real-time, AI-driven image guidance and visual confirmation of tool-in-lesion, LungVision® aims to significantly enhance diagnostic yield and procedural confidence. This capability is crucial for enabling earlier and more definitive diagnoses of lung cancer, ultimately leading to improved patient outcomes. The system is also designed to be cost-effective and integrate seamlessly with existing equipment, making advanced lung cancer interventions more accessible.

Beyond diagnostics, BodyVision Medical is expanding its focus to include the precise delivery of localized therapies for lung lesions, such as surgical markers for VATS or radio-surgery, and minimally invasive treatment tools like radio-frequency or microwave ablation. The company emphasizes a hardware-light design, offering a portable and affordable solution that minimizes radiation exposure compared to traditional 3D systems, further benefiting both patients and clinical staff.

Focus Areas

Lung cancer diagnostics AI-powered intraoperative imaging real-time navigation bronchoscopy pulmonary lesions minimally invasive procedures augmented reality imaging

Business Intelligence

Key InvestorsADIP, Zohar Gilon, Pontifax Venture Capital
PartnershipsHealthcare Links, SumTage Enterprise Co., Ltd. (Taiwan), Scanmed Technology Pte Ltd (Singapore), ElsMor Medical System Ltd. (Israel), Supri Artigos Médicos Hospitalares Ltd. (Brazil), DeLeC Científica Uruguaya (Bolivia, Argentina, Paraguay, Uruguay), Bio Scan (Mexico), Kral Medical Solutions, Paragon Care (Australia, New Zealand), Prism Technologies (Hong Kong, Macao, Greater Bay Area, Romania), AMCO Incorporated (Japan), Moss S.P.A. (Europe), Assiz & Sarah Healthcare (India), DK Healthcare Co., Ltd. (South Korea)
TechnologyAI-driven intraoperative imaging, AI Tomo (tomosynthesis-based imaging), LungVision platform, real-time 3D reconstruction from 2D X-ray, cloud-based machine learning, multi-modality image registration, augmented reality approach, C-Arm Based Tomography (CABT)
FDA Clearances3 cleared products (estimated)

What Physicians Need to Know

Lung Cancer Diagnostics
BodyVision Medical specializes in advanced AI-driven imaging for the early and definitive diagnosis of lung cancer. Their LungVisionu00ae system empowers clinicians to accurately locate and biopsy small pulmonary lesions.
AI-Powered Intraoperative Imaging
The LungVisionu00ae system utilizes proprietary AI Tomou00ae technology to transform images from any 2D C-arm into real-time, near-cone beam CT quality 3D images during bronchoscopy procedures. This eliminates the need for costly 3D fluoroscopy systems.
Real-time Navigation & Augmented Reality
The system provides real-time augmented endobronchial fluoroscopic navigation and guidance, allowing physicians to see the actual lesion and tool location intraoperatively. This corrects for CT-to-body divergence, a common challenge in traditional methods.
Minimally Invasive Procedures
BodyVision Medical's technology enhances the precision of minimally invasive bronchoscopic biopsies, enabling access to smaller, more peripheral, and fluoroscopically invisible lesions.
Key Differentiators
BodyVision Medical stands out with its AI Tomou00ae technology, providing 3D imaging comparable to cone-beam CT at significantly lower radiation doses and costs. Its real-time, intraoperative imaging eliminates CT-to-body divergence, leading to diagnostic yields approaching 90% and beyond. The system is hardware-light, portable, and compatible with most existing C-arms and bronchoscopy tools.
Technology Stack
The core technology stack includes advanced Artificial Intelligence and Machine Learning algorithms, proprietary AI Tomou00ae technology for 3D reconstruction from 2D fluoroscopy, multimodal image fusion, and C-Arm Based Tomography (CABT). The LungVisionu00ae System is a software-driven platform.
Physician Tip

For physicians, BodyVision Medical's LungVisionu00ae system offers increased confidence and precision in lung nodule biopsies due to real-time, visual confirmation of the tool-in-lesion, even for challenging cases. This translates to improved diagnostic accuracy and higher yields, enabling earlier lung cancer detection and better patient outcomes. The system's ease of use, reduced procedural duration, and lower radiation exposure for both patients and staff contribute to a more efficient and safer workflow. Furthermore, its compatibility with existing equipment minimizes the need for significant capital investment, making advanced imaging accessible.

The LungVisionu00ae system is designed for seamless integration with most existing 2D and 3D C-arms, navigation platforms, bronchoscopes (including robotic systems like Ethicon Monarchu2122 and Ion by Intuitive), and standard biopsy tools. This broad compatibility allows for flexible deployment and enhances existing interventional pulmonology suites without requiring extensive equipment upgrades.

Products by BodyVision Medical

1 product in the directory

LungVision
BodyVision Medical
Oncology AI
BodyVision Medical's LungVision system is an AI-powered intraoperative imaging and navigation platform that transforms 2D C-arm X-rays into real-time 3D CT-like scans for precise lung cancer diagnosis and intervention.

Reviews & Opinions

No web reviews on file yet for BodyVision Medical. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about BodyVision Medical.

Loading videos...

Videos load interactively. If none appear, search YouTube for BodyVision Medical →

View all on YouTube

Press & Coverage

PRNewswire
Body Vision Medical Receives Innovative Technology Contract from Vizient for LungVisionu00ae
Body Vision Medical's LungVisionu00ae AI-driven image guidance system has been awarded an Innovative Technology contract from Vizient, Inc., the largest provider-driven healthcare performance improvement company in the U.S.. This contract signifies the system's unique qualities that can potentially improve the healthcare industry, as recommended by hospital experts on Vizient's customer-led councils.
2024-07
Body Vision Medical
Body Vision Medical's Latest LungVisionu00ae Software Enhances AI Tomography, Improves Virtual Bronchoscopy and Introduces Revised
Body Vision Medical announced a software update for its LungVisionu00ae platform (v2.27), which includes an enhanced AI Tomou00ae imaging algorithm with a larger field of view, improved virtual bronchoscopy, and a better pathway planning experience.. This update aims to provide clinicians with improved user experience, particularly during peripheral scope navigation, to achieve high diagnostic success.
2024-08
PR Newswire
Body Vision Medical Receives Regulatory Approval for LungVisionu00ae in Australia, Expanding Access to AI-Driven Advanced Imaging for Lung Cancer Diagnosis
Body Vision Medical's LungVisionu00ae advanced imaging system has received regulatory approval from the Therapeutic Goods Administration (TGA) in Australia.. This approval, in partnership with ParagonCare, expands access to AI-driven imaging for early and accurate lung cancer diagnosis in Australia and New Zealand.
2025-03
PR Newswire
Body Vision Medical Expands Access to AI Tomou00ae with Major LungVisionu00ae Platform Upgrade
Body Vision Medical has upgraded its LungVision platform to provide universal access to AI Tomo imaging, allowing it to be used with nearly any fluoroscopic C-arm model.. This advancement aims to improve early and accurate lung cancer diagnosis worldwide by reconstructing 3D views from 2D imaging systems, eliminating the need for costly 3D fluoroscopy systems.
2025-08
PR Newswire
Body Vision Medical Receives Pre-Market Approval for LungVisionu00ae in Singapore, Advancing AI-Powered Imaging for Early Lung Cancer Diagnosis
Body Vision Medical's LungVision advanced imaging platform has received Pre-Market Approval from Singapore's Health Sciences Authority (HSA), enabling its full commercialization in Singapore.. This approval is a significant step in improving early and accurate lung cancer diagnosis in Singapore, where lung cancer is a major health concern.
2025-08
Start LLC
Body Vision Medical Receives Regulatory Approval for LungVisionu00ae in India, Expanding Access to AI-Driven Advanced Imaging for Lung Cancer Diagnosis
Body Vision Medical's LungVision AI-powered advanced imaging system has received regulatory approval from the Central Drugs Standard Control Organization (CDSCO) in India.. This approval, in partnership with Assiz & Sarah Healthcare, aims to address the need for earlier diagnosis of suspicious pulmonary nodules in India.
2025-09
Thoracic Cancer (via PMC)
The LungVision navigational platform for peripheral lung nodule biopsy and the added value of cryobiopsy
A prospective, single-center study evaluated the diagnostic yield and safety of the LungVision system for peripheral pulmonary nodule biopsy.. The study, funded by Body Vision Medical, found an overall diagnostic yield of 77.8%, with the second-generation system achieving 81.8%.
2021-07
PR Newswire
Body Vision Closing $20 Million in Series C Funding
Body Vision Medical closed $20 million in Series C funding to streamline commercialization and manufacturing for its LungVisionu2122 2.0 Platform.. The LungVisionu2122 2.0 Platform, which features AI Tomography, fused imaging, cloud-based machine learning, and multi-modality image registration, received FDA clearance in May 2019.
2019-09

Frequently Asked Questions

BodyVision Medical's LungVision system utilizes AI-powered intraoperative imaging and real-time augmented fluoroscopic navigation to improve the diagnostic yield of bronchoscopy for peripheral pulmonary lesions. It transforms 2D C-arm images into real-time 3D views, correcting for CT-to-body divergence and providing visual tool-in-lesion confirmation, which increases precision and confidence during minimally invasive procedures.
BodyVision Medical primarily offers the LungVision System, an AI-driven platform for real-time intraoperative imaging and navigation during bronchoscopy. This system includes proprietary AI Tomo technology and integrates with the LungVision Tool, a specialized lung navigation catheter, to guide endotherapy accessories to small pulmonary nodules.
BodyVision Medical's LungVision system has received FDA clearance in the U.S. (starting in 2017 for the system and 2018 for the tool) and CE marking in Europe (2021), along with regulatory approvals in several other countries. While specific details on data security protocols were not extensively detailed in the search results, medical device companies typically adhere to stringent healthcare data privacy regulations like HIPAA to ensure patient information protection.
The LungVision system is designed to be a cost-effective solution, integrating with existing standard bronchoscopy suite equipment and conventional C-arms, thereby minimizing capital outlay. It offers lower capital and per-case costs compared to other navigation systems like electromagnetic navigation bronchoscopy, robotics, or cone-beam CT. The system also features optional disposables to manage per-procedure costs.
BodyVision Medical provides comprehensive clinical training and case support to all customers after the initial purchase to ensure proficiency and success. They also offer refresher training, education for new staff, and advanced training for experienced users, alongside extended warranty service plans for optimal system performance and long-term value.
The LungVision system is designed for broad compatibility, integrating seamlessly with most existing C-arms, standard bronchoscopes, and robotic bronchoscopy platforms like Intuitive's Ion and Ethicon's Monarch. BodyVision Medical has also established strategic distribution partnerships globally with companies such as Ziehm Imaging, Moss S.P.A., Prism Technologies, Paragon Care, Kral Medical Solutions, and AMCO Incorporated to expand market access.
Founded in 2014, BodyVision Medical is a Series C company that has raised $28.5 million in funding and employs between 51-200 individuals as of July 2024. The company is actively expanding its global presence through numerous distribution agreements, aiming to make its AI-driven imaging technology accessible in many new markets, indicating a strong growth trajectory and commitment to long-term market penetration.

Investors

Who's funded BodyVision Medical.

Related Companies

Visiopharm is a leading provider of AI-driven precision pathology software, catering to both research and diagnostic applications. For physicians, Visiopharm offers advanced tools that transform pathology through image analysis, aiming to enhance precision and productivity in pathology labs. The company has developed nine diagnostic algorithms cleared under IVDR for EU and UK customers, which provide […]

TSI (Transworld Systems Inc.) is a long-standing company primarily known for its debt collection and business process outsourcing services. While they serve various industries, including healthcare, their core offering is focused on accounts receivable management and collections rather than healthcare-specific AI development. They provide solutions to help healthcare providers manage patient accounts, improve cash flow, […]

TrialX is a healthcare AI company specializing in clinical research and space health informatics. The company develops platforms designed to connect patients with clinical trials and facilitate research data collection. Their offerings include an enterprise patient recruitment platform (iConnect) that provides a clinical trials finder (Dory), study website builders, pre-screeners, referral tracking, and volunteer registries. […]

Thinkitive is a global IT services and solutions company that specializes in digital transformation, enterprise application services, outsourced product development, and a testing center of excellence. For physicians, Thinkitive offers a range of AI-driven healthcare solutions designed to streamline clinical and administrative workflows, enhance patient care, and improve operational efficiency. Their services include custom healthcare […]

Taction Software is a U.S.-based healthcare IT and custom software development company specializing in HIPAA-compliant solutions. They build AI-powered applications for healthcare, ranging from rapid clinical AI prototypes to production-grade systems with EHR integration, ambient documentation, and predictive analytics. The company focuses on transforming healthcare delivery through secure, compliant, and innovative software solutions that aim […]

SUPERWISE offers an enterprise AI governance and operations platform designed to help organizations, including those in healthcare, deploy and manage autonomous AI systems with oversight and control. The platform addresses governance, compliance, and operational challenges associated with AI and machine learning deployments. It features real-time guardrails for AI systems, model observability capabilities, and compliance automation, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.